Biolase, Inc.

Biolase, Inc.

Biolase, Inc.

Overview
Date Founded

1987

Headquarters

27042 Towne Centre Drive,Suite 270,Lake Forest, CA 92610

Type of Company

Public

Employees (Worldwide)

135

Industries

Medical Products & Equipment
Other Business & Consulting Services
Industrial Machinery & Manufacturing
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.

Contact Data
Trying to get in touch with decision makers at Biolase, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Director, President, Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer

Vice President of Engineering & Chief Technology Officer

Benefit Plan Administrator

Vice President, Innovation & Business Development

Vice President, Dental & Clinical Affairs & Chief Dental Officer

Vice President, Operations

Vice President, APAC, EMEA & Latin America

Vice President, Finance

Vice President, Dental Education & Professional Relations

Board of Directors

Advisor at Atos Digital Health Solutions, Inc.

Director, President, Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer at Biolase, Inc.

Former Senior Vice President & Chief Financial Officer at DexCom, Inc.

Former Global Chief Medical Officer at Guardant Health, Inc.

Former Principal Investigator-Laboratory of Oral Connective Tissue Biology at National Institute of Arthritis and Musculoskeletal and Skin Diseases

Executive Director at American Dental Association

Member, Board of Directors at Biolase, Inc.

Member, Board of Directors at Biolase, Inc.

Medicinal Chemistry & Drug Discovery Consultant at Inhibikase Therapeutics, Inc.

Paths to Biolase, Inc.
Potential Connections via
Relationship Science
You
Biolase, Inc.
Owners & Shareholders
Details Hidden

Perkins Capital Management seeks to generate a positive real rate of return over an extended period of years for their clients. Investment strategies vary based on the type of account and the client's investment objectives, as well as the style of the individual portfolio manager. the firm's two main account types are equity and balanced.Perkins' approach to equity investing can be characterized as a search for opportunity. Their primary focus is on companies which appear to be undergoing positive change that may not be recognized in the market place. Such changes include new products, processes, strategies or management. They also search for companies that are likely candidates for acquisition by another company. Situations like this could provide higher earnings, and when acknowledged by others in the market place, could result in a higher price earnings ratio. Generally, equity investments will be held for a longer period of time in individual (taxable) accounts than they will be held in a pension or IRA (tax deferred) account. This provides the client with potentially lower capital gains on their taxable accounts.Perkins' fixed income investment approach seeks maximum income consistent with high quality investments. In their balanced accounts, the firm analyzes the outlook for both short-term and long-term interest rates. Perkins assesses both the domestic and international economic scene. In their opinion, the most important factors when selecting fixed income securities are the credit rating, yield curve analysis and liquidity. Perkins prefers a minimum credit rating of A by Moody’s or Standard & Poor’s rating service. They analyze the yield curves of government, corporate, and municipal bonds looking for inequities in yields which may provide an opportunity. Assessing liquidity requires that the security have excellent marketability.

Details Hidden

Perkins Capital Management seeks to generate a positive real rate of return over an extended period of years for their clients. Investment strategies vary based on the type of account and the client's investment objectives, as well as the style of the individual portfolio manager. the firm's two main account types are equity and balanced.Perkins' approach to equity investing can be characterized as a search for opportunity. Their primary focus is on companies which appear to be undergoing positive change that may not be recognized in the market place. Such changes include new products, processes, strategies or management. They also search for companies that are likely candidates for acquisition by another company. Situations like this could provide higher earnings, and when acknowledged by others in the market place, could result in a higher price earnings ratio. Generally, equity investments will be held for a longer period of time in individual (taxable) accounts than they will be held in a pension or IRA (tax deferred) account. This provides the client with potentially lower capital gains on their taxable accounts.Perkins' fixed income investment approach seeks maximum income consistent with high quality investments. In their balanced accounts, the firm analyzes the outlook for both short-term and long-term interest rates. Perkins assesses both the domestic and international economic scene. In their opinion, the most important factors when selecting fixed income securities are the credit rating, yield curve analysis and liquidity. Perkins prefers a minimum credit rating of A by Moody’s or Standard & Poor’s rating service. They analyze the yield curves of government, corporate, and municipal bonds looking for inequities in yields which may provide an opportunity. Assessing liquidity requires that the security have excellent marketability.

Recent Transactions
Details Hidden

Biolase, Inc. issued USD Common Stock - Bought Deal

Details Hidden

Biolase, Inc. issued USD Common Stock

Details Hidden

Biolase, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onBiolase, Inc. issued USD Common Stock - Bought Deal

Underwriter

Advised onBiolase, Inc. issued USD Common Stock - Bought Deal

Escrow Agent

Advised onBiolase, Inc. issued USD Common Stock - Bought Deal

Legal Advisor

Advised onBiolase, Inc. issued USD Common Stock

Executive Managing Director of Investment Banking, Investment Banking

Advised onBiolase, Inc. issued USD Common Stock - Bought Deal

Head-Investment Banking & Senior Managing Director

Advised onBiolase, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Former Chairman & Chief Executive Officer at Sientra, Inc.

Advisor

Senior Vice President at EVC Group, Inc.

Advisor

Co-Founder at MKR Group, Inc.

Clients

Dental Care Alliance LLC provides dental practice management services. Its management services include human resources, payroll and benefits, marketing, purchasing, accounting and accounts payable, insurance management, facility management, staff training, and integrated information technology. The company was founded by Steven R. Matzkin in 1991 and is headquartered in Sarasota, FL.

MEKICS Co., Ltd. engages in the manufacture and sale of respirators and patient monitoring systems. Its products include ventilator, respiratory care system, patient monior, pulse oximeter, and central monitoring system. The company was founded on November 26, 1998 and is headquartered in Paju, South Korea.

Key Stats and Financials As of 2020
Market Capitalization
$92M
Total Enterprise Value
$26M
Earnings Per Share
$-0.56
Revenue
$22.8M
EBITDAMargin
-79.18%
Enterprise Value / Sales
1.14x
TEVNet Income
-1.54x
Debt TEV
0.7x
Net Profit
$-16.8M
Total Debt
$18.3M
EBITDA
$-18M
Total Equity
$10M
Three Year Compounded Annual Growth Rate Of Revenue
-21.41%
Suppliers
Heico Corp. Industrial Machinery & Manufacturing | Hollywood, FL

HEICO Corp. engages in the design, manufacture, and sale of aerospace, defense, and electronic related products and services. It operates through the Flight Support Group and Electronic Technologies Group segments. The Flight Support Group segment designs, manufactures, repairs, overhauls, and distributes jet engine and aircraft component replacement parts. The Electronic Technologies Group segment designs and manufactures electronic, microwave, and electro-optical equipment and components, three-dimensional microelectronic and stacked memory products, high-speed interface products, high voltage interconnection devices, high voltage advanced power electronics products, power conversion products, underwater locator beacons, electromagnetic interference shielding, traveling wave tube amplifiers, harsh environment electronic connectors and other interconnect products, communications and electronic intercept receivers and tuners, crashworthy, and ballistically self-sealing auxiliary fuel systems for military rotorcraft, RF and microwave amplifiers, transmitters and receivers, satellite microwave modules, and integrated subsystems primarily for the aviation, defense, space, medical, telecommunications, and electronics industries. The company was founded in 1957 and is headquartered in Hollywood, FL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Biolase, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Biolase, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Biolase, Inc..